Latest Stories
Watts Water Technologies’s (NYSE:WTS) Q4: Beats On Revenue
Water management manufacturer Watts Water (NYSE:WTS) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales fell by 1.3% year on year to $540.4 million. Its non-GAAP profit of $2.05 per share was 7.3% above analysts’ consensus estimates.
Coty (NYSE:COTY) Misses Q4 Revenue Estimates
Beauty products company Coty (NYSE:COTY) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 3.3% year on year to $1.67 billion. Its non-GAAP profit of $0.11 per share was 47.7% below analysts’ consensus estimates.
Medpace (NASDAQ:MEDP) Posts Q4 Sales In Line With Estimates But Stock Drops
Clinical research company Medpace Holdings (NASDAQ:MEDP) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.7% year on year to $536.6 million. On the other hand, the company’s full-year revenue guidance of $2.16 billion at the midpoint came in 3.5% below analysts’ estimates. Its GAAP profit of $3.67 per share was 24.1% above analysts’ consensus estimates.